Tesla and Curevac have developed a vaccine printer
Already in June 2019 the German biotech company Curevac and Tesla subsidiary Grohmann have applied for a patent for a newly developed vaccination printer.
A newly developed mobile "RNA Printer" is able to produce over a hundred thousand vaccination dosages in a few weeks. Originally developed to combat diseases like rabies and yellow fever it could potentially be used to produce a future Covid-19 vaccine given the approval for medical use of the printer and a vaccine.